A. Topal and M. Başak, “Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer”, Eur Res J, vol. 11, no. 5, pp. 858–867, Sep. 2025, doi: 10.18621/eurj.1704067.